80 related articles for article (PubMed ID: 18037402)
1. The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells.
Valenti MT; Dalle Carbonare L; Bertoldo F; Donatelli L; Lo Cascio V
Eur J Pharmacol; 2008 Feb; 580(1-2):36-42. PubMed ID: 18037402
[TBL] [Abstract][Full Text] [Related]
2. Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells.
Iguchi K; Tatsuda Y; Usui S; Hirano K
Eur J Pharmacol; 2010 Sep; 641(1):35-40. PubMed ID: 20519142
[TBL] [Abstract][Full Text] [Related]
3. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
Jagadeesh S; Kyo S; Banerjee PP
Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
Dalle Carbonare L; Valenti MT; Azzarello G; Balducci E; Crepaldi G; Realdi G; Vinante O; Giannini S
Mol Cell Endocrinol; 2005 Aug; 240(1-2):23-31. PubMed ID: 15978718
[TBL] [Abstract][Full Text] [Related]
5. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells.
Merrell MA; Wakchoure S; Lehenkari PP; Harris KW; Selander KS
Eur J Pharmacol; 2007 Sep; 570(1-3):27-37. PubMed ID: 17640631
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
[TBL] [Abstract][Full Text] [Related]
8. Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.
Räikkönen J; Mönkkönen H; Auriola S; Mönkkönen J
Biochem Pharmacol; 2010 Mar; 79(5):777-83. PubMed ID: 19819230
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N
Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C is inhibited by bisphosphonates in prostate cancer PC-3 cells.
Tatsuda Y; Iguchi K; Usui S; Suzui M; Hirano K
Eur J Pharmacol; 2010 Feb; 627(1-3):348-53. PubMed ID: 19903468
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate treatment inhibits the growth of prostate cancer cells.
Lee MV; Fong EM; Singer FR; Guenette RS
Cancer Res; 2001 Mar; 61(6):2602-8. PubMed ID: 11289137
[TBL] [Abstract][Full Text] [Related]
12. Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.
Dumon JC; Journé F; Kheddoumi N; Lagneaux L; Body JJ
Eur Urol; 2004 Apr; 45(4):521-8; discussion 528-9. PubMed ID: 15041119
[TBL] [Abstract][Full Text] [Related]
13. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
Chua CW; Chiu YT; Yuen HF; Chan KW; Man K; Wang X; Ling MT; Wong YC
Clin Cancer Res; 2009 Jul; 15(13):4322-35. PubMed ID: 19509141
[TBL] [Abstract][Full Text] [Related]
14. Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro.
Dalle Carbonare L; Valenti MT; Bertoldo F; Fracalossi A; Balducci E; Azzarello G; Vinante O; Lo Cascio V
Aging Clin Exp Res; 2007 Apr; 19(2):91-6. PubMed ID: 17446718
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity.
Qian X; Cheng J; Chen A; Wang Y; Tao Y; Cao J; Feng Z
Oncol Rep; 2008 Feb; 19(2):575-81. PubMed ID: 18202810
[TBL] [Abstract][Full Text] [Related]
16. Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.
Tang J; Wang Z; Li X; Li J; Shi H
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):83-93. PubMed ID: 18437586
[TBL] [Abstract][Full Text] [Related]
17. Indole-3-carbinol inhibits telomerase activity and gene expression in prostate cancer cell lines.
Adler S; Rashid G; Klein A
Anticancer Res; 2011 Nov; 31(11):3733-7. PubMed ID: 22110194
[TBL] [Abstract][Full Text] [Related]
18. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
19. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
20. Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.
Tanaka T; Kawashima H; Ohnishi K; Matsumura K; Yoshimura R; Matsuyama M; Kuratsukuri K; Nakatani T
Anticancer Res; 2009 Apr; 29(4):1089-94. PubMed ID: 19414350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
